tradingkey.logo
tradingkey.logo
Search

Processa Pharmaceuticals Inc

PCSA
Add to Watchlist
2.130USD
+0.090+4.41%
Close 07-31 16:00ETQuotes delayed by 15 min
5.70MMarket Cap
LossP/E TTM

PCSA Income Statement

You can find the annual or quarterly income statement of Processa Pharmaceuticals Inc here for insights into the performance and operational efficiency of Processa Pharmaceuticals Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
----
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-86.76%5.00K
10.54%58.16K
-82.24%20.04K
85.60%37.76K
-79.45%14.40K
-58.21%52.62K
15.99%112.83K
5.96%20.34K
122.85%70.09K
156.66%125.91K
0.27%97.28K
31.38%19.20K
--31.45K
--49.06K
--97.02K
--14.61K
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
----
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-84.74%5.00K
-66.57%17.59K
-81.44%20.04K
61.02%32.76K
-70.50%13.14K
-55.68%52.62K
12.47%107.97K
5.96%20.34K
51.22%44.53K
144.51%118.73K
-1.05%96.00K
31.38%19.20K
--29.45K
--48.56K
--97.02K
--14.61K
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
----
68.52%42.62K
-84.32%11.01K
173.15%24.97K
-74.54%8.63K
-68.57%25.29K
14.09%70.19K
-24.62%9.14K
2.40%33.90K
137.20%80.45K
14.30%61.52K
-2.26%12.13K
--33.11K
--33.92K
--53.83K
--12.40K
Operating expenses
17.01%3.33M
35.37%3.70M
1.87%3.49M
28.19%3.95M
1.33%2.85M
10.74%2.73M
58.00%3.42M
13.54%3.08M
-31.57%2.81M
-57.42%2.47M
-64.21%2.17M
-47.51%2.71M
27.16%4.11M
72.15%5.80M
97.91%6.06M
75.66%5.17M
47.21%3.23M
-8.78%3.37M
220.29%3.06M
267.11%2.94M
122.42%2.19M
304.96%3.69M
-4.83%955.54K
-29.46%801.99K
11.74%986.12K
22.92%911.98K
-5.55%1.00M
-20.39%1.14M
-31.67%882.52K
-54.05%741.95K
549.06%1.06M
13695.27%1.43M
9340.26%1.29M
9100.65%1.61M
3195.85%163.77K
15.28%10.35K
-83.01%13.68K
---17.94K
-96.96%4.97K
-98.16%8.98K
-83.77%80.52K
-77.10%163.63K
-42.54%489.02K
-45.71%496.14K
-22.52%668.36K
-10.74%714.42K
10.32%851.09K
11.41%913.91K
6.96%862.65K
29.68%800.34K
53.63%771.49K
50.09%820.32K
--806.50K
--617.16K
--502.19K
--546.56K
R&D expenses
13.89%1.81M
23.43%2.11M
-27.36%1.66M
41.43%2.45M
3.21%1.59M
29.66%1.71M
98.61%2.29M
2.50%1.73M
-5.43%1.54M
-55.64%1.32M
-60.82%1.15M
-42.58%1.69M
64.79%1.63M
58.86%2.98M
92.56%2.94M
107.62%2.94M
-22.68%987.61K
23.93%1.87M
357.42%1.53M
520.35%1.42M
321.65%1.28M
376.16%1.51M
-13.57%333.75K
-56.77%228.28K
5.95%302.94K
-47.75%317.57K
-36.86%386.15K
-51.00%528.07K
-64.60%285.92K
--607.84K
--611.61K
1298265.06%1.08M
972985.54%807.66K
----
-100.00%0.00
-98.54%83.00
--83.00
--287.00
-66.51%574.00
-48.12%5.70K
-100.00%0.00
-85.39%1.71K
-83.97%10.98K
-88.23%11.74K
-87.27%9.75K
-78.85%11.73K
8.10%68.50K
39.29%99.77K
-17.21%76.61K
-13.43%55.47K
-57.20%63.36K
-50.29%71.63K
--92.53K
--64.07K
--148.04K
--144.10K
Depreciation, depletion, and amortization
0.00%301.00
0.00%301.00
48.28%301.00
116.55%301.00
116.55%301.00
115.00%301.00
147.56%203.00
--139.00
--139.00
-99.93%140.00
-99.96%82.00
----
-100.00%0.00
0.00%197.12K
0.73%197.12K
-0.86%197.12K
-1.10%197.12K
-1.90%197.12K
-2.61%195.70K
-1.05%198.83K
-0.81%199.32K
0.00%200.94K
0.00%200.94K
-0.00%200.94K
0.00%200.94K
-0.00%200.94K
-0.70%200.94K
0.86%200.94K
629.46%200.94K
--200.94K
--202.37K
--199.24K
--27.55K
----
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-99.87%159.00
-78.84%23.64K
4.68%117.91K
6.59%118.37K
18.41%125.84K
7.62%111.71K
9.89%112.64K
8.54%111.06K
3.16%106.28K
2120.41%103.80K
14236.78%102.51K
170431.67%102.32K
--103.02K
--4.67K
--715.00
--60.00
Other operating expenses
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.61M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-17.01%-3.33M
-35.37%-3.70M
-1.87%-3.49M
-28.19%-3.95M
-1.33%-2.85M
-10.74%-2.73M
-58.00%-3.42M
-13.54%-3.08M
31.57%-2.81M
57.42%-2.47M
64.21%-2.17M
47.51%-2.71M
-27.16%-4.11M
-72.15%-5.80M
-97.91%-6.06M
-75.66%-5.17M
-47.21%-3.23M
8.78%-3.37M
-220.29%-3.06M
-267.11%-2.94M
-122.42%-2.19M
-304.96%-3.69M
4.83%-955.54K
29.46%-801.99K
-11.74%-986.12K
-22.92%-911.98K
5.55%-1.00M
20.39%-1.14M
31.67%-882.52K
54.05%-741.95K
-549.06%-1.06M
-13695.27%-1.43M
-9340.26%-1.29M
-9100.65%-1.61M
-3195.85%-163.77K
-15.28%-10.35K
81.88%-13.68K
--17.94K
95.29%-4.97K
98.09%-8.98K
83.53%-75.52K
84.06%-105.47K
36.47%-468.98K
48.70%-458.38K
17.49%-653.96K
1.87%-661.79K
-9.50%-738.26K
-11.54%-893.57K
-2.26%-792.56K
-18.72%-674.43K
-66.40%-674.21K
-50.60%-801.12K
---775.04K
---568.10K
---405.17K
---531.95K
Net non-operating interest income (expenses)
Non-operating interest income
10.12%13.86K
361.08%27.77K
30.19%52.27K
-76.48%16.86K
-84.88%12.59K
-90.66%6.02K
-53.13%40.15K
--71.70K
--83.22K
16.19%64.52K
133.36%85.66K
----
----
1503.06%55.53K
1972.73%36.71K
306.84%7.38K
-67.96%1.58K
49.63%3.46K
14658.33%1.77K
9977.78%1.81K
495.90%4.94K
249.70%2.31K
-99.20%12.00
-99.47%18.00
-86.15%829.00
-91.86%662.00
-76.72%1.50K
26.74%3.40K
484.47%5.99K
-92.97%8.13K
--6.46K
--2.68K
--1.02K
--115.63K
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
84900.00%850.00
127350.00%2.55K
1638.89%1.25K
-53.10%174.00
-99.90%1.00
-99.49%2.00
-88.77%72.00
-71.31%371.00
-5.54%989.00
--393.00
-18.96%641.00
--1.29K
--1.05K
--0.00
--791.00
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-97.75%362.00
-33.75%15.69K
1274.72%31.22K
198.43%18.21K
250.00%16.10K
246.88%23.68K
-72.71%2.27K
-89.54%6.10K
-94.76%4.60K
--6.83K
-81.15%8.32K
-8.04%58.31K
41.64%87.74K
----
-30.26%44.16K
1.24%63.41K
10.41%61.95K
--63.32K
2.17%63.32K
5.42%62.63K
59.07%56.11K
-52.38%61.98K
-47.39%59.41K
-41.31%35.27K
327.63%62.79K
186.65%130.13K
234.58%112.94K
278.22%60.10K
-11.79%14.68K
30.73%45.40K
-51.69%33.75K
-67.89%15.89K
--16.64K
--34.73K
--69.86K
--49.48K
Gains from sale of securities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---42.77K
---154.99K
---1.07K
---1.07K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
---59.82K
--295.18K
----
----
----
----
----
----
----
100.00%0.00
----
----
----
---7.27M
100.00%0.00
100.00%0.00
----
100.00%0.00
97.45%-50.95K
---351.86K
----
---6.70M
---2.00M
----
----
----
----
----
----
----
----
----
----
-78.02%-36.36K
--5.45K
22.89%30.91K
----
---20.42K
100.00%0.00
101.66%25.16K
----
---85.00K
---1.52M
----
---822.21K
--0.00
100.00%0.00
---390.66K
----
----
---19.00K
----
----
----
----
----
- Gains from disposal of fixed assets
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---25.00K
100.00%0.00
100.00%0.00
----
---44.13K
---7.38K
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
----
--20.00K
----
----
----
----
----
----
----
----
----
--101.90K
--83.46K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-19.15%-3.38M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
81.52%-2.40M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-286.63%-13.01M
-93.60%-6.02M
-56.77%-5.16M
-47.44%-3.23M
67.79%-3.37M
1.02%-3.11M
-301.12%-3.29M
-118.33%-2.19M
-1017.57%-10.45M
-212.68%-3.14M
27.94%-821.25K
-13.77%-1.00M
-26.24%-935.01K
5.64%-1.00M
23.19%-1.14M
36.07%-881.13K
51.76%-740.64K
-425.89%-1.06M
-3362.83%-1.48M
-1722.54%-1.38M
-1590.79%-1.54M
-196.50%-202.48K
7.77%-42.85K
42.54%-75.63K
---90.81K
76.91%-68.29K
97.73%-46.46K
73.27%-131.62K
62.66%-295.72K
-140.97%-2.05M
63.37%-492.40K
-90.71%-1.54M
-10.17%-791.93K
-17.15%-851.19K
-64.66%-1.34M
-2.08%-806.88K
-19.45%-718.84K
-52.95%-726.57K
-40.60%-816.37K
---790.40K
---601.78K
---475.03K
---580.64K
Income tax
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
74.57%-181.75K
-73.78%-122.44K
-56.17%-137.17K
30.35%-89.25K
-345.05%-714.60K
50.12%-70.46K
48.51%-87.83K
1.67%-128.13K
-22.13%-160.56K
33.38%-141.25K
38.58%-170.60K
53.72%-130.30K
-6708.34%-131.47K
-11079.54%-212.01K
---277.78K
---281.53K
---1.93K
--1.93K
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
0.00%25.00
0.00%25.00
0.00%25.00
-50.00%25.00
--25.00
--25.00
--25.00
61.29%50.00
-100.00%0.00
-100.00%0.00
----
--31.00
--100.00
--50.00
--0.00
Income after tax
-19.15%-3.38M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
81.52%-2.40M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-308.70%-13.01M
-101.54%-6.02M
-63.58%-5.16M
-53.71%-3.23M
67.29%-3.18M
2.74%-2.99M
-330.46%-3.16M
-140.12%-2.10M
-1157.00%-9.73M
-255.67%-3.07M
24.32%-733.41K
-16.45%-874.34K
-27.13%-774.44K
-1.25%-863.52K
19.65%-969.08K
31.54%-750.83K
60.27%-609.17K
-317.21%-852.82K
-2714.58%-1.21M
-1350.27%-1.10M
-1588.66%-1.53M
-199.33%-204.41K
7.77%-42.85K
42.54%-75.63K
---90.81K
76.91%-68.29K
97.73%-46.46K
73.27%-131.62K
62.66%-295.74K
-140.96%-2.05M
63.37%-492.43K
-90.70%-1.54M
-10.17%-791.95K
-17.16%-851.22K
-64.67%-1.34M
-2.09%-806.92K
-19.43%-718.84K
-52.94%-726.57K
-40.60%-816.37K
---790.43K
---601.88K
---475.08K
---580.64K
Net income from continuous operations
-19.15%-3.38M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
81.52%-2.40M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-308.70%-13.01M
-101.54%-6.02M
-63.58%-5.16M
-53.71%-3.23M
67.29%-3.18M
2.74%-2.99M
-330.46%-3.16M
-140.12%-2.10M
-1157.00%-9.73M
-255.67%-3.07M
24.32%-733.41K
-16.45%-874.34K
-27.13%-774.44K
-1.25%-863.52K
19.65%-969.08K
31.54%-750.83K
60.27%-609.17K
-317.21%-852.82K
-2714.58%-1.21M
-1350.27%-1.10M
-1588.66%-1.53M
-199.33%-204.41K
7.77%-42.85K
42.54%-75.63K
---90.81K
76.91%-68.29K
97.73%-46.46K
73.27%-131.62K
62.66%-295.74K
-140.96%-2.05M
63.37%-492.43K
-90.70%-1.54M
-10.17%-791.95K
-17.16%-851.22K
-64.67%-1.34M
-2.09%-806.92K
-19.43%-718.84K
-52.94%-726.57K
-40.60%-816.37K
---790.43K
---601.88K
---475.08K
---580.64K
Net income from discontinued operations
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
-100.00%0.00
100.00%0.00
---17.00
---42.00
--3.26K
98.68%-2.00K
----
----
---152.18K
----
----
----
----
----
----
----
----
----
----
----
----
Non-recurring net income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-19.15%-3.38M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
81.52%-2.40M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-308.70%-13.01M
-101.54%-6.02M
-63.58%-5.16M
-53.71%-3.23M
77.83%-3.18M
2.74%-2.99M
-330.46%-3.16M
-140.12%-2.10M
-1020.67%-14.36M
-255.67%-3.07M
24.32%-733.41K
-16.45%-874.34K
-110.36%-1.28M
-1.25%-863.52K
19.65%-969.08K
31.54%-750.83K
60.27%-609.17K
-317.21%-852.82K
-2151.94%-1.21M
-1172.17%-1.10M
-1408.56%-1.53M
-158.24%-204.41K
0.65%-53.56K
40.27%-86.22K
---101.65K
74.18%-79.16K
97.39%-53.91K
77.97%-144.33K
64.84%-306.57K
-125.99%-2.06M
52.62%-655.20K
-392.28%-2.90M
6.52%-871.84K
-18.74%-912.35K
-51.08%-1.38M
33.78%-589.63K
-34.85%-932.60K
-41.06%-768.36K
-40.76%-915.31K
---890.43K
---691.59K
---544.70K
---650.25K
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
0.00%10.71K
-1.09%10.59K
--10.82K
0.00%10.82K
0.00%10.71K
1.10%10.71K
-79.60%10.82K
-82.49%10.71K
-72.53%10.59K
--1.39M
-75.18%53.05K
46.30%61.13K
-61.04%38.55K
----
138.29%213.76K
-39.98%41.79K
42.12%98.94K
--100.00K
--89.70K
--69.62K
--69.62K
Net income attributable to common shareholders
-19.15%-3.38M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
81.52%-2.40M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-308.70%-13.01M
-101.54%-6.02M
-63.58%-5.16M
-53.71%-3.23M
77.83%-3.18M
2.74%-2.99M
-330.46%-3.16M
-140.12%-2.10M
-1020.67%-14.36M
-255.67%-3.07M
24.32%-733.41K
-16.45%-874.34K
-110.36%-1.28M
-1.25%-863.52K
19.65%-969.08K
31.54%-750.83K
60.27%-609.17K
-317.21%-852.82K
-2151.94%-1.21M
-1172.17%-1.10M
-1408.56%-1.53M
-158.24%-204.41K
0.65%-53.56K
40.27%-86.22K
---101.65K
74.18%-79.16K
97.39%-53.91K
77.97%-144.33K
64.84%-306.57K
-125.99%-2.06M
52.62%-655.20K
-392.28%-2.90M
6.52%-871.84K
-18.74%-912.35K
-51.08%-1.38M
33.78%-589.63K
-34.85%-932.60K
-41.06%-768.36K
-40.76%-915.31K
---890.43K
---691.59K
---544.70K
---650.25K
Basic earnings per share
-332.73%-1.29
-91.47%-1.49
-74.97%-1.81
74.96%-0.25
73.08%-0.30
54.47%-0.78
33.00%-1.03
47.98%-1.01
68.71%-1.11
89.20%-1.71
79.25%-1.54
70.06%-1.94
13.35%-3.53
-290.92%-15.81
-93.23%-7.43
-58.10%-6.48
-41.60%-4.08
81.17%-4.04
64.97%-3.85
-54.11%-4.10
9.18%-2.88
-361.75%-21.48
-252.33%-10.98
24.20%-2.66
-16.67%-3.17
-110.95%-4.65
-0.95%-3.12
23.90%-3.51
37.57%-2.72
-29.10%-2.21
82.81%-3.09
3.20%-4.61
43.28%-4.35
81.12%-1.71
-155.15%-17.95
0.61%-4.76
40.23%-7.67
---9.05
74.20%-7.04
97.39%-4.79
78.01%-12.84
73.08%-27.27
-72.24%-183.40
64.39%-58.39
-286.56%-275.29
13.13%-101.31
0.60%-106.48
65.27%-163.96
47.28%-71.22
69.89%-116.62
-29.64%-107.12
-378.58%-472.11
---135.08
---387.29
---82.63
---98.65
Diluted earnings per share
-332.73%-1.29
-91.47%-1.49
-74.97%-1.81
74.96%-0.25
73.08%-0.30
54.47%-0.78
33.00%-1.03
47.98%-1.01
68.71%-1.11
89.20%-1.71
79.25%-1.54
70.06%-1.94
13.35%-3.53
-290.92%-15.81
-93.23%-7.43
-58.10%-6.48
-41.60%-4.08
81.17%-4.04
64.97%-3.85
-54.11%-4.10
9.18%-2.88
-361.75%-21.48
-252.33%-10.98
24.20%-2.66
-16.67%-3.17
-110.95%-4.65
-0.95%-3.12
23.90%-3.51
37.57%-2.72
-29.10%-2.21
82.81%-3.09
3.20%-4.61
43.28%-4.35
81.12%-1.71
-155.15%-17.95
0.61%-4.76
40.23%-7.67
---9.05
74.20%-7.04
97.39%-4.79
78.01%-12.84
73.08%-27.27
-72.24%-183.40
64.39%-58.39
-286.56%-275.29
13.13%-101.31
0.60%-106.48
65.27%-163.96
47.28%-71.22
69.89%-116.62
-29.64%-107.12
-378.58%-472.11
---135.08
---387.29
---82.63
---98.65
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Processa Pharmaceuticals Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing PCSA stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Processa Pharmaceuticals Inc's net income for the year?

Processa Pharmaceuticals Inc posted -13.56M in net income for fiscal year 2025.

How much net income did Processa Pharmaceuticals Inc post in the last quarter?

Processa Pharmaceuticals Inc reported -3.38M in net income for the latest quarter。

What was Processa Pharmaceuticals Inc's annual operating profit?

Processa Pharmaceuticals Inc's operating income was -13.99M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.